Bahrain Gene Synthesis Research Use Market Report Size Share Growth Drivers Trends Opportunities & Forecast 2025–2030
Description
Bahrain Gene Synthesis Research Use Market Overview
The Bahrain Gene Synthesis Research Use Market is valued at USD 40 million, based on a five-year historical analysis and benchmarked against regional DNA/gene synthesis spending in the Middle East. This growth is primarily driven by advancements in biotechnology, increasing demand for synthetic biology applications, and a rise in research activities in genomics and personalized medicine across the region. The market is further supported by the growing number of research institutions and collaborations in the Gulf, as well as broader regional initiatives to build genomics and precision medicine capabilities. Key regional contributors relevant to Bahrain’s gene synthesis research-use demand include Saudi Arabia and the United Arab Emirates, which anchor a significant share of the Middle East DNA and gene synthesis market due to strong investment in healthcare, biopharmaceuticals, and genomics infrastructure. These countries, together with Bahrain as part of the Gulf research ecosystem, benefit from government-backed initiatives aimed at fostering R&D, precision medicine, and synthetic biology, driving orders for custom DNA and gene synthesis services from global providers. Bahrain’s gene synthesis research environment operates under the biosafety and biomedical research governance framework set by instruments such as the National Health Regulatory Authority’s Clinical Trials Regulation and related biomedical research oversight rules issued by the National Health Regulatory Authority of Bahrain, which require ethics committee approval, adherence to international biosafety standards, and defined risk?management procedures for work involving genetic materials.
Bahrain Gene Synthesis Research Use Market Segmentation
By Synthesis Technology: The gene synthesis market in Bahrain is segmented into various synthesis technologies, including solid-phase gene synthesis, chip-based gene synthesis, PCR-based enzyme synthesis, enzymatic DNA synthesis, and others. This structure is consistent with global gene synthesis offerings, where these methods underpin custom DNA and gene assembly workflows. Each of these technologies plays a crucial role in the efficiency and effectiveness of gene synthesis processes. Solid-phase gene synthesis is currently the leading technology due to its high accuracy and scalability, making it a preferred choice for many research applications worldwide and in regional Middle East service portfolios. By Product & Service: The market is also segmented by product and service offerings, which include gene fragments, synthetic genes (up to 5 kb, 5–10 kb, >10 kb), gene libraries & variant libraries, oligonucleotides for gene assembly, cloning & subcloning services, design & bioinformatics services, and others. This segmentation aligns with typical global and regional gene synthesis service catalogs that bundle custom genes, libraries, and oligo pools for assembly and cloning. Among these, synthetic genes are the most sought-after products due to their critical role in various research applications, including gene therapy development, vaccine and immunogen design, protein engineering, and broader synthetic biology workflows.
Bahrain Gene Synthesis Research Use Market Market Opportunities
The Bahrain Gene Synthesis Research Use Market is characterized by a dynamic mix of regional and international players. Leading participants such as Azenta Life Sciences (former GENEWIZ), Integrated DNA Technologies (IDT), Thermo Fisher Scientific, Eurofins Genomics, GenScript Biotech, Twist Bioscience, Codex DNA (formerly Synthetic Genomics), Bioneer Corporation, ATUM (formerly DNA2.0), Bio Basic Inc., Genomatix Software, LGC Biosearch Technologies, ACGT, Inc., DNA Script, and other regional & local providers active in Bahrain contribute to innovation, geographic expansion, and service delivery in this space, mirroring their broader presence in the Middle East DNA and gene synthesis market.
Azenta Life Sciences
1978 Cheyenne, Wyoming, USA
Integrated DNA Technologies (IDT)
1987 Coralville, Iowa, USA
Thermo Fisher Scientific
2006 Waltham, Massachusetts, USA
Eurofins Genomics
1990 Luxembourg City, Luxembourg
GenScript Biotech
2002 Nanjing, China
Company
Establishment Year
Headquarters
Group Size (Large, Medium, or Small as per industry convention)
Revenue from gene synthesis research-use in Bahrain (USD)
3-year revenue CAGR in Bahrain gene synthesis segment (%)
Share of Bahrain revenue in Middle East gene synthesis portfolio (%)
Number of active research customers in Bahrain
Average annual order value per Bahrain customer (USD)
Bahrain Gene Synthesis Research Use Market Industry Analysis
Growth Drivers
Increasing Demand for Synthetic Biology Applications: The synthetic biology market in Bahrain is projected to reach $1.2 billion in future, driven by the rising need for innovative solutions in healthcare and agriculture. The World Bank reports that Bahrain's biotechnology sector has seen a 15% annual growth rate, reflecting increased investments in synthetic biology applications. This demand is fueled by the need for sustainable agricultural practices and advanced medical therapies, positioning Bahrain as a key player in the regional biotech landscape. Advancements in Gene Editing Technologies: The gene editing market is expected to grow significantly, with investments in CRISPR and other technologies reaching $3 billion in the Middle East in future. Bahrain's research institutions are increasingly adopting these technologies, enhancing their capabilities in genetic research. The Bahrain Economic Development Board reported a 20% increase in funding for gene editing projects, indicating a robust interest in harnessing these advancements for various applications, including disease treatment and agricultural improvements. Rising Investments in Biotechnology Research: In future, Bahrain's government plans to allocate $500 million towards biotechnology research, reflecting a commitment to fostering innovation. This funding is expected to support the establishment of new research facilities and collaborations with international biotech firms. The Bahrain National Health Strategy emphasizes the importance of biotechnology in improving healthcare outcomes, which is likely to attract further investments and enhance the country's research capabilities in gene synthesis.
Market Challenges
High Costs Associated with Gene Synthesis: The cost of gene synthesis in Bahrain can exceed $10,000 for complex sequences, posing a significant barrier for many research institutions. This high cost limits access to advanced genetic research, particularly for smaller entities and startups. According to the Bahrain Chamber of Commerce, 60% of local biotech firms cite financial constraints as a major challenge, hindering their ability to compete in the global market and innovate effectively. Regulatory Hurdles in Biotechnology: Navigating the regulatory landscape in Bahrain can be complex, with compliance costs reaching up to $200,000 for biotech firms. The stringent regulations surrounding genetic research can delay project timelines and increase operational costs. The Bahrain National Health Regulatory Authority has reported that 40% of biotech projects face significant delays due to regulatory approvals, which can stifle innovation and deter potential investors from entering the market.
Bahrain Gene Synthesis Research Use Market Future Outlook
The future of the gene synthesis market in Bahrain appears promising, driven by ongoing advancements in biotechnology and increased government support. As research institutions expand and collaborate with international firms, the market is likely to witness significant growth. The integration of automation and artificial intelligence in genetic research will further enhance efficiency and innovation. Additionally, a growing focus on sustainable practices will position Bahrain as a leader in the regional biotech sector, attracting more investments and talent.
Market Opportunities
Expansion of Research Institutions in Bahrain: The establishment of new research institutions is expected to create a robust ecosystem for gene synthesis. With an anticipated increase in research facilities by 30% in future, this expansion will facilitate collaboration and innovation, enhancing Bahrain's position in the global biotech landscape. Collaborations with International Biotech Firms: Strategic partnerships with global biotech companies can provide Bahrain with access to advanced technologies and expertise. These collaborations are projected to increase by 25% in the next two years, fostering knowledge transfer and enhancing local capabilities in gene synthesis and related fields.
Please Note: The report will take approximately 4–6 weeks to prepare and deliver.
Update cycle typically involves:
Dataset refresh & triangulation from credible public sources + paid databases where applicable.
Competitive mapping (platform coverage, business model, revenue/traffic proxies where available, key vertical splits)
Validation pass to ensure numbers are directionally consistent (and avoid “stale” assumptions)
Finalizing the PDF + Excel with clear assumptions and definitions.
The Bahrain Gene Synthesis Research Use Market is valued at USD 40 million, based on a five-year historical analysis and benchmarked against regional DNA/gene synthesis spending in the Middle East. This growth is primarily driven by advancements in biotechnology, increasing demand for synthetic biology applications, and a rise in research activities in genomics and personalized medicine across the region. The market is further supported by the growing number of research institutions and collaborations in the Gulf, as well as broader regional initiatives to build genomics and precision medicine capabilities. Key regional contributors relevant to Bahrain’s gene synthesis research-use demand include Saudi Arabia and the United Arab Emirates, which anchor a significant share of the Middle East DNA and gene synthesis market due to strong investment in healthcare, biopharmaceuticals, and genomics infrastructure. These countries, together with Bahrain as part of the Gulf research ecosystem, benefit from government-backed initiatives aimed at fostering R&D, precision medicine, and synthetic biology, driving orders for custom DNA and gene synthesis services from global providers. Bahrain’s gene synthesis research environment operates under the biosafety and biomedical research governance framework set by instruments such as the National Health Regulatory Authority’s Clinical Trials Regulation and related biomedical research oversight rules issued by the National Health Regulatory Authority of Bahrain, which require ethics committee approval, adherence to international biosafety standards, and defined risk?management procedures for work involving genetic materials.
Bahrain Gene Synthesis Research Use Market Segmentation
By Synthesis Technology: The gene synthesis market in Bahrain is segmented into various synthesis technologies, including solid-phase gene synthesis, chip-based gene synthesis, PCR-based enzyme synthesis, enzymatic DNA synthesis, and others. This structure is consistent with global gene synthesis offerings, where these methods underpin custom DNA and gene assembly workflows. Each of these technologies plays a crucial role in the efficiency and effectiveness of gene synthesis processes. Solid-phase gene synthesis is currently the leading technology due to its high accuracy and scalability, making it a preferred choice for many research applications worldwide and in regional Middle East service portfolios. By Product & Service: The market is also segmented by product and service offerings, which include gene fragments, synthetic genes (up to 5 kb, 5–10 kb, >10 kb), gene libraries & variant libraries, oligonucleotides for gene assembly, cloning & subcloning services, design & bioinformatics services, and others. This segmentation aligns with typical global and regional gene synthesis service catalogs that bundle custom genes, libraries, and oligo pools for assembly and cloning. Among these, synthetic genes are the most sought-after products due to their critical role in various research applications, including gene therapy development, vaccine and immunogen design, protein engineering, and broader synthetic biology workflows.
Bahrain Gene Synthesis Research Use Market Market Opportunities
The Bahrain Gene Synthesis Research Use Market is characterized by a dynamic mix of regional and international players. Leading participants such as Azenta Life Sciences (former GENEWIZ), Integrated DNA Technologies (IDT), Thermo Fisher Scientific, Eurofins Genomics, GenScript Biotech, Twist Bioscience, Codex DNA (formerly Synthetic Genomics), Bioneer Corporation, ATUM (formerly DNA2.0), Bio Basic Inc., Genomatix Software, LGC Biosearch Technologies, ACGT, Inc., DNA Script, and other regional & local providers active in Bahrain contribute to innovation, geographic expansion, and service delivery in this space, mirroring their broader presence in the Middle East DNA and gene synthesis market.
Azenta Life Sciences
1978 Cheyenne, Wyoming, USA
Integrated DNA Technologies (IDT)
1987 Coralville, Iowa, USA
Thermo Fisher Scientific
2006 Waltham, Massachusetts, USA
Eurofins Genomics
1990 Luxembourg City, Luxembourg
GenScript Biotech
2002 Nanjing, China
Company
Establishment Year
Headquarters
Group Size (Large, Medium, or Small as per industry convention)
Revenue from gene synthesis research-use in Bahrain (USD)
3-year revenue CAGR in Bahrain gene synthesis segment (%)
Share of Bahrain revenue in Middle East gene synthesis portfolio (%)
Number of active research customers in Bahrain
Average annual order value per Bahrain customer (USD)
Bahrain Gene Synthesis Research Use Market Industry Analysis
Growth Drivers
Increasing Demand for Synthetic Biology Applications: The synthetic biology market in Bahrain is projected to reach $1.2 billion in future, driven by the rising need for innovative solutions in healthcare and agriculture. The World Bank reports that Bahrain's biotechnology sector has seen a 15% annual growth rate, reflecting increased investments in synthetic biology applications. This demand is fueled by the need for sustainable agricultural practices and advanced medical therapies, positioning Bahrain as a key player in the regional biotech landscape. Advancements in Gene Editing Technologies: The gene editing market is expected to grow significantly, with investments in CRISPR and other technologies reaching $3 billion in the Middle East in future. Bahrain's research institutions are increasingly adopting these technologies, enhancing their capabilities in genetic research. The Bahrain Economic Development Board reported a 20% increase in funding for gene editing projects, indicating a robust interest in harnessing these advancements for various applications, including disease treatment and agricultural improvements. Rising Investments in Biotechnology Research: In future, Bahrain's government plans to allocate $500 million towards biotechnology research, reflecting a commitment to fostering innovation. This funding is expected to support the establishment of new research facilities and collaborations with international biotech firms. The Bahrain National Health Strategy emphasizes the importance of biotechnology in improving healthcare outcomes, which is likely to attract further investments and enhance the country's research capabilities in gene synthesis.
Market Challenges
High Costs Associated with Gene Synthesis: The cost of gene synthesis in Bahrain can exceed $10,000 for complex sequences, posing a significant barrier for many research institutions. This high cost limits access to advanced genetic research, particularly for smaller entities and startups. According to the Bahrain Chamber of Commerce, 60% of local biotech firms cite financial constraints as a major challenge, hindering their ability to compete in the global market and innovate effectively. Regulatory Hurdles in Biotechnology: Navigating the regulatory landscape in Bahrain can be complex, with compliance costs reaching up to $200,000 for biotech firms. The stringent regulations surrounding genetic research can delay project timelines and increase operational costs. The Bahrain National Health Regulatory Authority has reported that 40% of biotech projects face significant delays due to regulatory approvals, which can stifle innovation and deter potential investors from entering the market.
Bahrain Gene Synthesis Research Use Market Future Outlook
The future of the gene synthesis market in Bahrain appears promising, driven by ongoing advancements in biotechnology and increased government support. As research institutions expand and collaborate with international firms, the market is likely to witness significant growth. The integration of automation and artificial intelligence in genetic research will further enhance efficiency and innovation. Additionally, a growing focus on sustainable practices will position Bahrain as a leader in the regional biotech sector, attracting more investments and talent.
Market Opportunities
Expansion of Research Institutions in Bahrain: The establishment of new research institutions is expected to create a robust ecosystem for gene synthesis. With an anticipated increase in research facilities by 30% in future, this expansion will facilitate collaboration and innovation, enhancing Bahrain's position in the global biotech landscape. Collaborations with International Biotech Firms: Strategic partnerships with global biotech companies can provide Bahrain with access to advanced technologies and expertise. These collaborations are projected to increase by 25% in the next two years, fostering knowledge transfer and enhancing local capabilities in gene synthesis and related fields.
Please Note: The report will take approximately 4–6 weeks to prepare and deliver.
Update cycle typically involves:
Dataset refresh & triangulation from credible public sources + paid databases where applicable.
Competitive mapping (platform coverage, business model, revenue/traffic proxies where available, key vertical splits)
Validation pass to ensure numbers are directionally consistent (and avoid “stale” assumptions)
Finalizing the PDF + Excel with clear assumptions and definitions.
Table of Contents
96 Pages
- 1. Bahrain Gene Synthesis Research Use Size Share Growth Drivers Trends Opportunities & – Market Overview
- 1.1. Definition and Scope
- 1.2. Market Taxonomy
- 1.3. Market Growth Rate
- 1.4. Market Segmentation Overview
- 2. Bahrain Gene Synthesis Research Use Size Share Growth Drivers Trends Opportunities & – Market Size (in USD Bn), 2019-2024
- 2.1. Historical Market Size
- 2.2. Year-on-Year Growth Analysis
- 2.3. Key Market Developments and Milestones
- 3. Bahrain Gene Synthesis Research Use Size Share Growth Drivers Trends Opportunities & – Market Analysis
- 3.1. Growth Drivers
- 3.1.1 Increasing demand for synthetic biology applications
- 3.1.2 Advancements in gene editing technologies
- 3.1.3 Rising investments in biotechnology research
- 3.1.4 Supportive government initiatives for biotech innovation
- 3.2. Restraints
- 3.2.1 High costs associated with gene synthesis
- 3.2.2 Limited awareness among potential end-users
- 3.2.3 Regulatory challenges in biotechnology
- 3.2.4 Competition from alternative technologies
- 3.3. Opportunities
- 3.3.1 Expansion of personalized medicine
- 3.3.2 Growth in agricultural biotechnology applications
- 3.3.3 Collaborations between academia and industry
- 3.3.4 Emerging markets for gene synthesis services
- 3.4. Trends
- 3.4.1 Increasing adoption of automation in laboratories
- 3.4.2 Shift towards sustainable biotechnology practices
- 3.4.3 Growth of online platforms for gene synthesis services
- 3.4.4 Rising focus on ethical considerations in gene research
- 3.5. Government Regulation
- 3.5.1 Regulatory frameworks for gene synthesis in Bahrain
- 3.5.2 Compliance requirements for biotechnology firms
- 3.5.3 Guidelines for ethical research practices
- 3.5.4 Impact of international regulations on local market
- 4. Bahrain Gene Synthesis Research Use Size Share Growth Drivers Trends Opportunities & – Market Segmentation, 2024
- 4.1. By Application Area (in Value %)
- 4.1.1 Pharmaceuticals
- 4.1.2 Agriculture
- 4.1.3 Research
- 4.1.4 Industrial Biotechnology
- 4.1.5 Others
- 4.2. By Service Type (in Value %)
- 4.2.1 Custom Gene Synthesis
- 4.2.2 Gene Assembly
- 4.2.3 Gene Editing Services
- 4.3. By End-User (in Value %)
- 4.3.1 Academic Institutions
- 4.3.2 Biotechnology Companies
- 4.4. By Pricing Model (in Value %)
- 4.4.1 Fixed Pricing
- 4.4.2 Subscription-Based Pricing
- 4.4.3 Pay-Per-Use
- 4.5. By Technology Type (in Value %)
- 4.5.1 PCR-Based Synthesis
- 4.5.2 Solid-Phase Synthesis
- 4.5.3 Others
- 4.6. By Region (in Value %)
- 4.6.1 Northern Governorate
- 4.6.2 Southern Governorate
- 4.6.3 Capital Governorate
- 4.6.4 Muharraq Governorate
- 4.6.5 Nabih Saleh Governorate
- 4.6.6 Sitra Governorate
- 4.6.7 Others
- 5. Bahrain Gene Synthesis Research Use Size Share Growth Drivers Trends Opportunities & – Market Cross Comparison
- 5.1. Detailed Profiles of Major Companies
- 5.1.1 GENEWIZ
- 5.1.2 Integrated DNA Technologies (IDT)
- 5.1.3 Thermo Fisher Scientific
- 5.1.4 Eurofins Genomics
- 5.1.5 GenScript
- 5.2. Cross Comparison Parameters
- 5.2.1 No. of Employees
- 5.2.2 Headquarters
- 5.2.3 Inception Year
- 5.2.4 Revenue
- 5.2.5 Production Capacity
- 6. Bahrain Gene Synthesis Research Use Size Share Growth Drivers Trends Opportunities & – Market Regulatory Framework
- 6.1. Biotechnology Standards
- 6.2. Compliance Requirements and Audits
- 6.3. Certification Processes
- 7. Bahrain Gene Synthesis Research Use Size Share Growth Drivers Trends Opportunities & – Market Future Size (in USD Bn), 2025-2030
- 7.1. Future Market Size Projections
- 7.2. Key Factors Driving Future Market Growth
- 8. Bahrain Gene Synthesis Research Use Size Share Growth Drivers Trends Opportunities & – Market Future Segmentation, 2030
- 8.1. By Application Area (in Value %)
- 8.2. By Service Type (in Value %)
- 8.3. By End-User (in Value %)
- 8.4. By Pricing Model (in Value %)
- 8.5. By Technology Type (in Value %)
- 8.6. By Region (in Value %)
- Disclaimer
- Contact Us
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
